Corindus Vascular Robotics Inc (CVRS) Short Interest Up 1.4% in January

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) was the target of a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 13,318,394 shares, an increase of 1.4% from the January 15th total of 13,133,613 shares. Approximately 15.9% of the shares of the company are short sold. Based on an average daily trading volume, of 360,423 shares, the days-to-cover ratio is currently 37.0 days.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Jane Street Group LLC purchased a new position in Corindus Vascular Robotics in the fourth quarter valued at $36,000. HRT Financial LLC purchased a new position in Corindus Vascular Robotics in the fourth quarter valued at $44,000. Virtu Financial LLC purchased a new position in Corindus Vascular Robotics in the fourth quarter valued at $64,000. Citadel Advisors LLC grew its holdings in shares of Corindus Vascular Robotics by 205.4% during the third quarter. Citadel Advisors LLC now owns 115,728 shares of the medical equipment provider’s stock worth $164,000 after purchasing an additional 77,829 shares during the last quarter. Finally, Barclays PLC purchased a new position in shares of Corindus Vascular Robotics during the fourth quarter worth about $325,000.

Separately, Zacks Investment Research upgraded Corindus Vascular Robotics from a “hold” rating to a “buy” rating and set a $1.50 price objective for the company in a research note on Friday, November 9th.

NYSEAMERICAN:CVRS opened at $1.43 on Wednesday. Corindus Vascular Robotics has a 52 week low of $0.70 and a 52 week high of $1.65.

COPYRIGHT VIOLATION NOTICE: This report was posted by Fairfield Current and is the sole property of of Fairfield Current. If you are viewing this report on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The original version of this report can be read at https://www.fairfieldcurrent.com/news/2019/03/06/corindus-vascular-robotics-inc-cvrs-sees-large-growth-in-short-interest.html.

About Corindus Vascular Robotics

Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures.

Further Reading: Why is cost of goods sold important?

Receive News & Ratings for Corindus Vascular Robotics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Corindus Vascular Robotics and related companies with MarketBeat.com’s FREE daily email newsletter.